exo.incHealthcare / Medical DevicesFounded: 2016Funding to Date: $650.6MM
Exo is a developer of a high-performance handheld ultrasound platform.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
08/02/2021 | Series C | $220.75MM | $xx.xx | $636.17MM | RA Capital Management, BlackRock, Sands Capital, Avidity Partners, Pura Vida Investments | |
Price per Share
$xx.xx
Shares Outstanding
37,684,090
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
RA Capital Management, BlackRock, Sands Capital, Avidity Partners, Pura Vida Investments
|
||||||
08/24/2020 | Series B++ | $3.7MM | $xx.xx | $256.65MM | Fiscus Ventures, Reimagined Ventures, Action Potential Venture Capital, TDK Ventures, Solasta Ventures, Intel Capital, Applied Ventures, Bold Capital, Creative Ventures, Longevity Vision Fund, Nautilus Venture Partners, OSF Healthcare, Rising Tide Fund, Innovation Growth Ventures, Wanxiang Healthcare Investments | |
Price per Share
$xx.xx
Shares Outstanding
1,076,300
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Fiscus Ventures, Reimagined Ventures, Action Potential Venture Capital, TDK Ventures, Solasta Ventures, Intel Capital, Applied Ventures, Bold Capital, Creative Ventures, Longevity Vision Fund, Nautilus Venture Partners, OSF Healthcare, Rising Tide Fund, Innovation Growth Ventures, Wanxiang Healthcare Investments
|
||||||
08/24/2020 | Series B+ | $49.7MM | $xx.xx | $256.65MM | Fiscus Ventures, Reimagined Ventures, Action Potential Venture Capital, TDK Ventures, Solasta Ventures, Intel Capital, Applied Ventures, Bold Capital, Creative Ventures, Longevity Vision Fund, Nautilus Venture Partners, OSF Healthcare, Rising Tide Fund, Innovation Growth Ventures, Wanxiang Healthcare Investments | |
Price per Share
$xx.xx
Shares Outstanding
15,902,980
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Fiscus Ventures, Reimagined Ventures, Action Potential Venture Capital, TDK Ventures, Solasta Ventures, Intel Capital, Applied Ventures, Bold Capital, Creative Ventures, Longevity Vision Fund, Nautilus Venture Partners, OSF Healthcare, Rising Tide Fund, Innovation Growth Ventures, Wanxiang Healthcare Investments
|
||||||
08/05/2019 | Series B | $36.67MM | $xx.xx | $120.46MM | OSF Ventures, Intel Capital | |
Price per Share
$xx.xx
Shares Outstanding
17,463,120
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
OSF Ventures, Intel Capital
|
||||||
10/10/2017 | Series A+ | $7.65MM | $xx.xx | $48.56MM | Rising Tide, Applied Ventures, Bold Capital Partners | |
Price per Share
$xx.xx
Shares Outstanding
5,506,304
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Rising Tide, Applied Ventures, Bold Capital Partners
|
||||||
10/10/2017 | Series A | $6.82MM | $xx.xx | $48.56MM | Rising Tide, Applied Ventures, Bold Capital Partners | |
Price per Share
$xx.xx
Shares Outstanding
8,476,902
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Rising Tide, Applied Ventures, Bold Capital Partners
|